Overview

Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
Cetuximab, Paclitaxel, Carboplatin and Radiation for Esophageal, Gastroesophageal Junction and Gastric Cancer
Phase:
Phase 2
Details
Lead Sponsor:
Brown University
Collaborator:
Bristol-Myers Squibb
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Cetuximab
Paclitaxel